Who Paid My Doc
PD1 + longitudinal study
Research payments
$2,134,686
Through program year 2024, $2,134,686 in research payments was reported against PD1 + longitudinal study, across 995 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $104,026 | 9 |
| 2021 | Research | $1,061,905 | 346 |
| 2020 | Research | $930,783 | 592 |
| 2019 | Research | $37,972 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Edward Arrowsmith Chattanooga, TN Named on 235 payments
- Susanna Ulahannan Ponca City, OK Named on 160 payments
- Johanna Bendell Nashville, TN Named on 146 payments
- Todd Gersten Wellington, FL Named on 123 payments
- Ivor Percent Port Charlotte, FL Named on 95 payments
- Maen Hussein Leesburg, FL Named on 59 payments
- Viralkumar Bhanderi Tallahassee, FL Named on 46 payments
- Deepak Kilari Milwaukee, WI Named on 32 payments
- Gregory Durm Indianapolis, IN Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.